http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1268171-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_492278f7fa4823de459db7b61382bd22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
filingDate | 1983-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1986-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5008ca0b500939c8be3c5421b6805d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512678a2b5d650f23093d2432c478b76 |
publicationDate | 1986-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SU-1268171-A1 |
titleOfInvention | Method of prophylaxis of acute adrenocortical insufficiency in surgical operations |
abstract | The invention relates to medicine and can be used to prevent acute adrenocortical insufficiency in operations. The purpose of the invention is to reduce complications. Before the operation, clinical and laboratory examination is performed. In the case of withdrawal of steroids treatment 2-5 months prior to surgical treatment, hydrocortisone is administered once at 1 mg / kg before surgery. When signs of acute adrenocortical insufficiency appear, this drug is administered (L even during surgery. If steroid therapy is discontinued less than 2 months before surgery, hydrocortisone is administered before, during and after surgery.) During steroid therapy, hydrocortisone is administered once before the operation, 1 mg / kg. During the operation, 1-2 daily doses of the drug are administered and after the operation a 1-day dose of the drug. |
priorityDate | 1983-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255 |
Total number of triples: 14.